Insulin/IGF-I-signaling pathway: An evolutionarily conserved mechanism of longevity from yeast to humans, Am. J. Physiol, vol.285, pp.1064-1071, 2003. ,
Epigenetics: Intrauterine growth retardation (IUGR) modifies the histone code along the rat hepatic IGF-1 gene, FASEB J, vol.23, pp.2438-2449, 2009. ,
The regulation of IGF-1 gene transcription and splicing during development and aging, Front. Endocrinol, vol.4, p.39, 2013. ,
Control of aging and longevity by IGF-I signaling, Exp. Gerontol, vol.40, pp.867-872, 2005. ,
Healthspan and longevity can be extended by suppression of growth hormone signaling, Mamm. Genome, vol.27, pp.289-299, 2016. ,
Functionally significant insulin-like growth factor I receptor mutations in centenarians, Proc. Natl. Acad. Sci. U.S.A, vol.105, pp.3438-3442, 2008. ,
Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans, Sci. Transl. Med, vol.3, pp.70-83, 2011. ,
Low insulin-like growth factor-1 level predicts survival in humans with exceptional longevity, Aging Cell, vol.13, pp.769-771, 2014. ,
,
, J. Clin. Endocrinol. Metab, vol.88, pp.3664-3667, 2003.
Growth hormone replacement in adults-Current standards and new perspectives, Best Pract. Res. Clin. Endocrinol. Metab, vol.29, pp.115-123, 2015. ,
Pleiotropic effects of growth hormone signaling in aging, Trends Endocrinol. Metab, vol.22, pp.437-442, 2011. ,
Growth hormone secretion is diminished and tightly controlled in humans enriched for familial longevity, Aging Cell, vol.15, pp.1126-1131, 2016. ,
Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism, Proc. Natl. Acad. Sci. U.S.A, vol.86, pp.8083-8087, 1989. ,
Exon 3-deleted and full-length growth hormone receptor polymorphism frequencies in an Iranian population, Res. Pharm. Sci, vol.9, pp.489-494, 2014. ,
Speciesspecific alternative splice mimicry at the growth hormone receptor locus revealed by the lineage of retroelements during primate evolution, J. Biol. Chem, vol.275, pp.18664-18669, 2000. ,
A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone, Nat. Genet, vol.36, pp.720-724, 2004. ,
Growth hormone (GH) pharmacogenetics: Influence of GH receptor exon 3 retention or deletion on first-year growth response and final height in patients with severe GH deficiency, J. Clin. Endocrinol. Metab, vol.91, pp.1076-1080, 2006. ,
The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children, J. Clin. Endocrinol. Metab, vol.91, pp.659-664, 2006. ,
Exon 3-deleted/fulllength growth hormone receptor polymorphism genotype frequencies in Spanish short small-for-gestational-age (SGA) children and adolescents (n = 247) and in an adult control population (n = 289) show increased fl/fl in short SGA, J. Clin. Endocrinol. Metab, vol.91, pp.5038-5043, 2006. ,
Growth hormone receptor polymorphism and growth hormone therapy response in children: A Bayesian meta-analysis, Am. J. Epidemiol, vol.175, pp.867-877, 2012. ,
Impact of the exon 3-deleted growth hormone (GH) receptor polymorphism on baseline height and the growth response to recombinant human GH therapy in GH-deficient (GHD) and non-GHD children with short stature: A systematic review and meta-analysis, J. Clin. Endocrinol. Metab, vol.94, pp.3721-3730, 2009. ,
,
Height-reducing variants and selection for short stature in Sardinia, Nat. Genet, vol.47, pp.1352-1356, 2015. ,
,
,
Meta-analysis of dense genecentric association studies reveals common and uncommon variants associated with height, Meena Kumari on behalf of the Whitehall II Study and the WHII 50K Group, vol.88, pp.6-18, 2011. ,
The exon-3 deletion of the growth hormone receptor (GHR) gene still has a limited impact in clinical endocrinology, J. Clin. Endocrinol. Metab, vol.95, pp.56-59, 2010. ,
Heterozygous nonsense mutation in exon 3 of the growth hormone receptor (GHR) in severe GH insensitivity (Laron syndrome) and the issue of the origin and function of the GHRd3 isoform, J. Clin. Endocrinol. Metab, vol.88, pp.1705-1710, 2003. ,
GHR exon 3 polymorphism: Association with type 2 diabetes mellitus and metabolic disorder, Growth Horm. IGF Res, vol.17, pp.392-398, 2007. ,
Genetic and epigenetic modulation of growth hormone sensitivity studied with the IGF-1 generation test, J. Clin. Endocrinol. Metab, vol.100, pp.919-925, 2015. ,
JAK2, and STAT3 may be the intracellular determinants of longevity implicated in the progeric influence of obesity: Insulin, IGF-1, and leptin may all conspire to promote stem cell exhaustion, Med. Hypotheses, vol.66, pp.570-576, 2006. ,
The paradox of the insulin/IGF-1 signaling pathway in longevity, Mech. Ageing Dev, vol.125, pp.397-403, 2004. ,
A polymorphism in the growth hormone receptor is associated with height in children with Prader-Willi syndrome, Am. J. Med. Genet. A, vol.155, pp.2970-2973, 2011. ,
Human Ageing Genomic Resources: Integrated databases and tools for the biology and genetics of ageing, Nucleic Acids Res, vol.41, pp.1027-1033, 2013. ,
Evolutionary medicine: From dwarf model systems to healthy centenarians?, Science, vol.299, pp.1342-1346, 2003. ,
, The Biology of Human Longevity: Inflammation, Nutrition, and Aging in the Evolution of Lifespans, 2007.
Aging and longevity: The IGF-1 enigma, Circ. Res, vol.97, pp.411-414, 2005. ,
Can growth hormone (GH) accelerate aging? Evidence from GH-transgenic mice, Neuroendocrinology, vol.78, pp.210-216, 2003. ,
Polymorphic variants of insulin-like growth factor I (IGF-I) receptor and phosphoinositide 3-kinase genes affect IGF-I plasma levels and human longevity: Cues for an evolutionarily conserved mechanism of life span control, J. Clin. Endocrinol. Metab, vol.88, pp.3299-3304, 2003. ,
Association analysis of insulin-like growth factor-1 axis parameters with survival and functional status in nonagenarians of the Leiden Longevity Study, Aging, vol.7, pp.956-963, 2015. ,
The growth hormone receptor: Mechanism of activation and clinical implications, Nat. Rev. Endocrinol, vol.6, pp.515-525, 2010. ,
Influence of the d3GH receptor polymorphism on the metabolic and biochemical phenotype of GH-deficient adults at baseline and during short-and long-term recombinant human GH replacement therapy, Eur. J. Endocrinol, vol.163, pp.361-368, 2010. ,
Influence of growth hormone receptor (GHR) exon 3 and -202A/C IGFBP-3 genetic polymorphisms on clinical and biochemical features and therapeutic outcome of patients with acromegaly, Pituitary, vol.18, pp.666-673, 2015. ,
The GH receptor exon 3 deleted/full-length polymorphism is associated with central adiposity in the general population, Eur. J. Endocrinol, vol.172, pp.123-128, 2015. ,
HALCyon Study Team, A multi-cohort study of polymorphisms in the GH/IGF axis and physical capability: The HALCyon programme, PLOS ONE, vol.7, p.29883, 2012. ,
Lower circulating insulin-like growth factor-I is associated with better cognition in females with exceptional longevity without compromise to muscle mass and function, Aging, vol.8, pp.2414-2424, 2016. ,
Disruption of the GH receptor gene in adult mice increases maximal lifespan in females, Endocrinology, vol.157, pp.4502-4513, 2016. ,
Antagonistic pleiotropy and the stress theory of aging, Biogerontology, vol.8, pp.613-617, 2007. ,
Increasing circulating IGFBP1 levels improves insulin sensitivity, promotes nitric oxide production, lowers blood pressure, and protects against atherosclerosis, Diabetes, vol.61, pp.915-924, 2012. ,
, The Strategy of Genes, 1957.
BRCA 1 and 2-A genetic link to familial breast and ovarian cancer, Medscape Womens Health, vol.2, p.7, 1997. ,
Plasma HDL levels highly correlate with cognitive function in exceptional longevity, J. Gerontol., Ser. A, vol.57, pp.712-715, 2002. ,
Clinical phenotype of families with longevity, J. Am. Geriatr. Soc, vol.52, pp.274-277, 2004. ,
Unique lipoprotein phenotype and genotype associated with exceptional longevity, JAMA, vol.290, pp.2030-2040, 2003. ,
Lipoprotein genotype and conserved pathway for exceptional longevity in humans, PLOS Biol, vol.4, p.113, 2006. ,
Abnormality of gait as a predictor of non-Alzheimer's dementia, N. Engl. J. Med, vol.347, pp.1761-1768, 2002. ,
The Cardiovascular Health Study: Design and rationale, Ann. Epidemiol, vol.1, pp.263-276, 1991. ,
Growth hormone receptor (GHR) exon 3 polymorphism status detection by dual-enzyme-linked immunosorbent assay (ELISA), J. Clin. Endocrinol. Metab, vol.98, pp.77-81, 2013. ,
PedCheck: A program for identification of genotype incompatibilities in linkage analysis, Am. J. Hum. Genet, vol.63, pp.259-266, 1998. ,
, were supported by INSERM with additional contribution from Association de Recherche sur le Diabète and an institutional grant from Novo Nordisk France. CHS was supported by contracts N01-HC-85079 through N01-HC-85086, N01-HC-35129, N01 HC-55222, N01 HC-15103, N01-HC-75150, and N01-HC-45133; grant number U01 HL080295 from the National Heart, Lung, and Blood Institute; U19 AG023122 from the National Institute on Aging Longevity Consortium; and P30 AG021334 from the National Institute on Aging, Claude D. Pepper Older Americans Independence Centers; and grant R01 HL-071862 (to A.R.), with additional contribution from the National Institute of Neurological Disorders and Stroke. A full list of participating CHS investigators and institutions can be, Genotyping services for CHS were provided by the Center for Inherited Disease Research (CIDR). CIDR is fully funded through a federal contract from the NIH to the Johns Hopkins University (contract number N01-HG-65403), 2016.
, , 2017.
The GH receptor exon 3 deletion is a marker of male-specific exceptional longevity associated with increased GH sensitivity and taller stature, Sci. Adv, vol.3, p.1602025, 2017. ,
URL : https://hal.archives-ouvertes.fr/inserm-02320509
, , p.1602025
, Sci Adv REFERENCES
, This article cites 54 articles, 9 of which you can access for free